Lysine

Lysine

SCHEMBL28689762

COCCO.NCCCCC(N)C(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.67
DDAH1 O94760 2/20 0.50
ARG2 P78540 4/20 0.43
ARG1 P05089 3/20 0.43
NOS2 P35228 5/20 0.42
NOS1 P29475 4/20 0.42
NOS3 P29474 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
RNPEP Q9H4A4 1/20 0.42
BLM P54132 1/20 0.41
MEN1 O00255 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL28931663 0.91 GSR (0.59) GSRDDAH1ARG2ARG1NOS2
Lysine SCHEMBL28676597 0.89 GSR (0.61) GSRDDAH1ARG2ARG1NOS2
Lysine SCHEMBL28278541 0.86 GSR (0.83) GSRDDAH1ARG2ARG1NOS2
Lysine SCHEMBL27895772 0.84 GSR (0.87) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL27881240 0.84 GSR (0.87) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL29075874 0.84 GSR (0.95) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL302610 0.82 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL1696587 0.82 GSR (0.83) GSRARG2ARG1NOS2NOS1
Lysine SCHEMBL1671166 0.82 GSR (0.83) GSRDDAH1ARG2ARG1NOS2
Lysine SCHEMBL15753994 0.82 GSR (0.83) GSRARG2ARG1NOS2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109438568-B Preparation and application of monodisperse polyethylene glycol monomethyl ether modified interleukin IL-12 prodrug 湖南华腾制药有限公司 2022-01-11 CN disclosed